Form 8-K - Current report:
SEC Accession No. 0001558370-22-005262
Filing Date
2022-04-11
Accepted
2022-04-11 06:29:17
Documents
39
Period of Report
2022-04-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20220411x8k.htm   iXBRL 8-K 53004
2 EX-99.1 krbp-20220411xex99d1.htm EX-99.1 37447
3 GRAPHIC krbp-20220411xex99d1g026.jpg GRAPHIC 198109
4 GRAPHIC krbp-20220411xex99d1g006.jpg GRAPHIC 131734
5 GRAPHIC krbp-20220411xex99d1g010.jpg GRAPHIC 165779
6 GRAPHIC krbp-20220411xex99d1g008.jpg GRAPHIC 64334
7 GRAPHIC krbp-20220411xex99d1g002.jpg GRAPHIC 306305
8 GRAPHIC krbp-20220411xex99d1g024.jpg GRAPHIC 122710
9 GRAPHIC krbp-20220411xex99d1g015.jpg GRAPHIC 162289
10 GRAPHIC krbp-20220411xex99d1g013.jpg GRAPHIC 165442
11 GRAPHIC krbp-20220411xex99d1g019.jpg GRAPHIC 146620
12 GRAPHIC krbp-20220411xex99d1g011.jpg GRAPHIC 68060
13 GRAPHIC krbp-20220411xex99d1g018.jpg GRAPHIC 65398
14 GRAPHIC krbp-20220411xex99d1g007.jpg GRAPHIC 221675
15 GRAPHIC krbp-20220411xex99d1g014.jpg GRAPHIC 92058
16 GRAPHIC krbp-20220411xex99d1g025.jpg GRAPHIC 110541
17 GRAPHIC krbp-20220411xex99d1g017.jpg GRAPHIC 124009
18 GRAPHIC krbp-20220411xex99d1g009.jpg GRAPHIC 120286
19 GRAPHIC krbp-20220411xex99d1g005.jpg GRAPHIC 184876
20 GRAPHIC krbp-20220411xex99d1g004.jpg GRAPHIC 176961
21 GRAPHIC krbp-20220411xex99d1g012.jpg GRAPHIC 227769
22 GRAPHIC krbp-20220411xex99d1g022.jpg GRAPHIC 136711
23 GRAPHIC krbp-20220411xex99d1g023.jpg GRAPHIC 123233
24 GRAPHIC krbp-20220411xex99d1g003.jpg GRAPHIC 63377
25 GRAPHIC krbp-20220411xex99d1g001.jpg GRAPHIC 198109
26 GRAPHIC krbp-20220411xex99d1g020.jpg GRAPHIC 64195
27 GRAPHIC krbp-20220411xex99d1g021.jpg GRAPHIC 89988
28 GRAPHIC krbp-20220411xex99d1g016.jpg GRAPHIC 178033
  Complete submission text file 0001558370-22-005262.txt   5336644

Data Files

Seq Description Document Type Size
29 EX-101.SCH krbp-20220411.xsd EX-101.SCH 3048
30 EX-101.LAB krbp-20220411_lab.xml EX-101.LAB 16586
31 EX-101.PRE krbp-20220411_pre.xml EX-101.PRE 10539
33 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20220411x8k_htm.xml XML 5046
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 22818449
SIC: 2836 Biological Products, (No Diagnostic Substances)